Johnson and Johnson

2026-09-18 23:01; UTC

Johnson & Johnson's shares advanced modestly in after-market trading, continuing positive momentum following five consecutive sessions that ended higher.

2026-09-17 23:06; UTC

Johnson & Johnson is trading slightly higher in after-market hours, continuing a trend of five consecutive sessions finishing higher since Thursday's close.

2026-09-16 23:06; UTC

Johnson & Johnson's shares are trading lower in after-market hours, briefly dipping to a low while remaining below their 20-day moving average.

2026-09-15 23:01; UTC

Johnson & Johnson shares are lower in after-market trading amid negative market sentiment following a sharp decline in the New York Empire State Manufacturing Index.

2026-09-14 23:06; UTC

Johnson & Johnson shares rose in after-market trading following the final survival analysis results of the Phase 3 PAPILLON study for RYBREVANT and chemotherapy.

2026-09-12 00:01; UTC

Johnson & Johnson shares rose in after-hours trading amid reports of Apollo Global Management discussing a $20 billion acquisition of its DePuy Synthes unit.

2026-09-11 23:41; UTC

Johnson & Johnson shares higher after news of Apollo Global Management's interest in acquiring its $20 billion orthopedics unit, DePuy Synthes.

2026-09-10 20:07; UTC

Johnson & Johnson shares are lower despite receiving CE Marking for its ACUVUE OASYS MAX 2-Week lens, with HSBC raising its price target to $320.

2026-09-09 23:01; UTC

Johnson & Johnson shares are higher in after-market trading, reflecting a modest increase since Wednesday's close despite three consecutive sessions of declines.

2026-09-08 20:02; UTC

Johnson & Johnson shares are lower today amid declines in the Pharmaceuticals sub-sector, despite strong merger and acquisition capacity estimated at $80 billion.

2026-09-05 00:01; UTC

Johnson & Johnson shares are higher in after-market trading, with no specific news driving the move. The stock reached a session high earlier today.

2026-09-04 20:08; UTC

Shares of Johnson & Johnson are lower as Timothy Schmid exercised stock options for 33,597 shares valued at approximately $4.39 million.

2026-09-03 23:41; UTC

Johnson & Johnson's shares are lower in after-market trading following FDA approval of IMAAVY and a jury verdict in a talc case.

2026-09-02 23:06; UTC

Johnson & Johnson will participate in the Deutsche Bank 2026 Healthcare Summit on September 17. Shares are higher in after-market trading following the announcement.

2026-09-01 20:01; UTC

Johnson & Johnson shares are higher today, reaching the upper end of their one-month trading range during the session. No specific news was identified.

2026-08-31 23:06; UTC

Johnson & Johnson shares are higher in after-market trading following the announcement of an investor conference call on October 13, 2026, for third-quarter results.

2026-08-29 00:01; UTC

Johnson & Johnson shares higher in after-market trading following FDA approval of Stelara for pediatric ulcerative colitis treatment, expanding its market potential.

2026-08-28 20:08; UTC

Johnson & Johnson shares are higher during Friday's session, reflecting a modest gain since Thursday's close amid routine trading and rising Treasury yields.

2026-08-27 23:01; UTC

Johnson & Johnson shares advanced in after-market trading, recovering from earlier volatility. Broader market context includes a decline in initial jobless claims.

2026-08-26 23:06; UTC

Johnson & Johnson shares are lower during after-market hours, reflecting a decline since Wednesday's close amid broader market concerns over persistent inflation pressures.

2026-08-25 23:06; UTC

Johnson & Johnson shares are lower in after-market trading, reflecting broader market trends and a decline in crude oil prices influencing investor sentiment.

2026-08-24 19:06; UTC

Johnson & Johnson's shares are higher today, recovering from earlier volatility and trading above its 20-day moving average near a one-month peak.

2026-08-21 23:06; UTC

Johnson & Johnson shares are higher in after-hours trading, maintaining a position above the 20-day moving average despite a slight pullback from earlier gains.

2026-08-20 23:41; UTC

Johnson & Johnson shares are higher in after-market trading following operational sales growth and a raised full-year outlook amid recent FDA clearances for its bronchoscopy software.

2026-08-19 19:32; UTC

Johnson & Johnson shares advance as EVP Jennifer Taubert exercises options for 15,000 shares valued at $2.38 million and receives regulatory clearance for MONARCH QUEST 3 software.

2026-08-18 23:56; UTC

Johnson & Johnson returns the C-CAR039 program to AbelZeta, while discussions about a potential acquisition of Legend Biotech continue. Shares are roughly flat in after-market trading.

2026-08-17 23:06; UTC

Johnson & Johnson's shares are roughly flat in after-market trading. The stock remains positioned above its 20-day moving average and near its one-month range.

2026-08-14 19:46; UTC

Johnson & Johnson shares are lower as pharmaceuticals sub-sector weakness persists. The stock reached a session low earlier before recovering slightly.

2026-08-13 19:21; UTC

Johnson & Johnson shares are higher, reflecting broader market gains amid stabilizing inflation pressures and a drop in crude oil prices.

2026-08-12 23:26; UTC

Johnson & Johnson shares are lower in after-market trading, despite initially rising above Wednesday's close. The stock remains above its 20-day moving average.